# US 2021/0277076 A1 · Alpha-synuclein substrates and methods for making and using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277076 A1
- Document ID: US20210277076A1
- Status: Published application
- Kind: A1
- Application number: 17/323,919
- Filed: 2021-05-18
- Published: 2021-09-09
- Earliest claimed: 2019-09-04
- Assignees: Amprion, Inc.
- Applicants: Amprion, Inc.
- Inventors: Luis Concha; Carly Farris; Bret Holguin; Yihua Ma
- Web page: https://patentgrep.com/patent/US20210277076A1

## CPC

- C07K 14/47: from mammals
- B01L 3/5027: {by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip}
- C07K 1/34: by filtration, ultrafiltration or reverse osmosis
- C12N 1/06: Lysis of microorganisms
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12R 2001/19: Escherichia coli
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

An expression vector is provided for production of human alpha-synuclein (αS) protein or a conservative variant thereof that exhibits a decreased tendency to self-aggregate in an αS seed amplification assay (SAA). The expression vector comprises a nucleic acid sequence coding for human αS protein or a conservative variant, the nucleic acid sequence comprising codons that have been optimized to produce human αS protein or a conservative variant when expressed by a host cell such as E. coli. The codons have been optimized to avoid amino acid misincorporation in the expressed protein. Methods for purification of the expressed protein are also provided.

## Claims

### Claim 1

A nucleic acid sequence having at least 95% identity with SEQ ID NO: 1, excluding SEQ ID NO: 3.

### Claim 2

An expression vector for production of a protein comprising SEQ ID NO: 6, the expression vector comprising a nucleic acid sequence comprising at least 95% identity with SEQ ID NO: 1, excluding SEQ ID NO: 3.

### Claim 3 (depends on 2)

The expression vector of claim 2, further comprising a nucleic acid sequence having at least 95% identity with SEQ ID NO: 2, excluding SEQ ID NO: 4.

### Claim 4 (depends on 2)

A protein comprising SEQ ID NO: 6, prepared using the expression vector of claim 2.

### Claim 5

A method for preparing a protein comprising SEQ ID NO: 6, the method comprising:
transforming into an enterobacterial host cell an expression vector comprising a nucleic acid sequence comprising at least 95% identity with SEQ ID NO: 1, excluding SEQ ID NO: 3;
culturing the enterobacterial host cell under conditions effective to produce the protein; and
obtaining the protein from the enterobacterial host cell.

### Claim 6 (depends on 5)

The method of claim 5, wherein the expression vector further comprises a nucleic acid sequence having at least 95% identity with SEQ ID NO: 2, excluding SEQ ID NO: 4.

### Claim 7 (depends on 5)

The method of claim 5, wherein the enterobacteria comprises Escherichia coli.

### Claim 8 (depends on 5)

The method of claim 5, wherein the obtaining comprises lysing the transformed cell using a microfluidizer.

### Claim 9 (depends on 8)

The method of claim 8, wherein the lysing produces a cell lysate, and the method further comprises:
(i) clarifying the cell lysate; and
(ii) contacting the clarified lysate with a synthetic adsorbent of crystalline calcium silicate hydrate.

### Claim 10 (depends on 8)

The method of claim 8, wherein the lysing produces a cell lysate, and the method further comprises:
(i) clarifying the cell lysate; and
(ii) titrating the clarified lysate with acid to a pH of about 3.5 or less.

### Claim 11 (depends on 8)

The method of claim 8, wherein the lysing produces a cell lysate, and the method further comprises:
(i) clarifying the cell lysate;
(ii) titrating the clarified lysate with acid to a pH of about 2 or less; and
(iii) adding lipopolysaccharide.

### Claim 12 (depends on 11)

The method of claim 11, further comprising, prior to adding the lipopolysaccharide:
(i) neutralizing the acidified lysate;
(ii) filtering the neutralized lysate;
(iii) subjecting the filtered lysate to chromatography to yield the protein;
(iv) filtering the protein;
(v) dialyzing the filtered protein; and
(vi) filtering the dialyzed protein.

### Claim 13 (depends on 12)

The method of claim 12, further comprising filtering the dialyzed, filtered protein at least a second time.

### Claim 14 (depends on 8)

The method of claim 8, wherein the lysing produces a cell lysate, and the method further comprises:
(i) clarifying the cell lysate;
(ii) titrating the clarified lysate with acid to a pH of about 3.5 to produce a first acidified lysate;
(iii) clarifying the first acidified lysate; and
(iv) acidifying the clarified, first acidified lysate to a pH of less than about 2 to produce a second acidified lysate.

### Claim 15 (depends on 14)

The method of claim 14, further comprising:
(i) clarifying the second acidified lysate;
(ii) filtering the second acidified lysate;
(iii) neutralizing the filtered, second acidified lysate;
(iv) filtering the neutralized lysate;
(v) subjecting the filtered, neutralized lysate to chromatography to yield the protein;
(vi) filtering the protein;
(vii) dialyzing the filtered protein; and
(viii) filtering the dialyzed protein.
